Drugs Hypothalamus and Pituitary (linger) Flashcards
Octreotide
somatostatin analog
lanreotide
somatostatin analog
Pegvisomant
GH antagonists
Inhibits binding of GH and prevents signal transduction
More effective than somatostatin analogs
Bromocriptine
Dopamine Agonists
coupled to Gαi/o, which inhibits adenylyl cyclase and decreases cAMP
Cabergoline
Dopamine Agonists
coupled to Gαi/o, which inhibits adenylyl cyclase and decreases cAMP
what are the vasopressin receptor agonists x2
vasopressin
desmopressin- longer half life
Peptide hormone released in response to rising plasma tonicity or failing blood pressure; antidiuretic and vasopressor properties
MOA: agonist at vasopressin (V1 and V2) receptors (GPCRs)
what are the vasopressin receptor antagonists x2
conivaptan
tolvaptan
antagonists at V2 receptors
Promotes the excretion of free water (without loss of serum electrolytes) resulting in net fluid loss, increased urine output, decreased urine osmolality, and subsequent restoration of normal serum sodium levels
mecasermin
Insulin Like growth factor 1 agonist (recombinant human IGF-1)
used for IGF-1 deficiency
and children with GH gene deletions who have developed neutralizing antibodies
most common adverse effect of mecasermin
hypoglycemia
what are the 2 strategies of growth hormone antagonists and which drugs represent the different strategies?
Reduce secretion of growth hormone
Somatostatin analogs: octreotide, lanreotide
Block action of growth hormone at receptors
Growth hormone receptor antagonist: pegvisomant
through what signalling pathway does prolactin act
JAK/STAT cytokine receptors
what is the clinical use of D2 receptor agonists
hyperprolactinemia (also acromegaly, Parkinson disease)
Shrink pituitary PRL-secreting tumors, lower circulating PRL levels, and restore ovulation in 70% of women with microadenomas and 30% of women with macroadenomas
what are the adverse effects of D2 receptor agonists
Nausea, headache, light-headedness, orthostatic hypotension, fatigue are most common adverse effects
clinical use of vasopressin agonists
pituitary diabetes insipidus, hemophilia A, von Willebrand disease
clinical use of vasopressin antagonists
Used in the treatment of clinically significant hypervolemic or euvolemic hyponatremia (associated with heart failure, cirrhosis, or SIADH)
which hormones activate kinase linked receptors of the JAK/STAT superfamily
GH and Prolactin
these are single chain protein hormones
which hormones act via GPCR’s
TSH
FSH
LH
ACTH
ACTH release is regulated by what
corticotropin releasing hormone (CRH)
what inhibits ACTH and CRH
cortisol
what stimulates and prohibits production of GH
stimulates–> GHRH
inhibited –> Somatostatin
which hormones of the pituitary act directly on target tissues
prolactin, vasopressin, ADH
what happens with disruption of the pituitary stalk and the hypothalamohypohysial portal vessels
prolactin levels will increase
ACTH, TSH, FSH, LH, GH levels will decrease